Company: AGIO
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001439222-25-000009
Chunk: 3

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 15
Chunk 3
---
ant and Thirty-Eight Sidney Street Limited LLC10-Q001-36014August 1, 201910.110.17Fourth Amendment to Lease, dated as of April 11, 2019, by and between the Registrant and Forest City 88 Sidney Street, LLC10-Q001-36014August 1, 201910.210.18Third Amendment of Lease, dated as of April 11, 2019, by and between the Registrant and UP 64 Sidney Street, LLC10-Q001-36014August 1, 201910.310.19Sublease Agreement, dated July 27, 2021, between the Registrant and Prime Medicine, Inc. (64 Sidney Street)10-K001-36014February 24, 202210.4410.20Sublease Agreement, dated April 14, 2023, between the Registrant and Watershed Informatics, Inc.10-K001-36014February 15, 202410.2110.21#Letter Agreement, dated July 8, 2022, between the Registrant and Brian Goff10-Q001-36014August 4, 202210.210.22#Form of Inducement Stock Option Agreement for Brian Goff10-Q001-36014August 4, 202210.310.23#Form of Inducement Restricted Stock Unit Agreement for Brian Goff10-Q001-36014August 4, 202210.4

87

Table of Contents

10.24#**Form of Inducement Performance Stock Unit Agreement for Brian Goff10-Q001-36014August 4, 202210.510.25#Letter Agreement, dated as of September 16, 2022, between the Registrant and Cecilia Jones10-Q001-36014November 3, 202210.510.26#Form of Inducement Stock Option Agreement for Cecilia JonesS-8333- 267624September 26, 202299.110.27#Form of Inducement Restricted Stock Unit Agreement for Cecilia JonesS-8333- 267624September 26, 202299.210.28#**Form of Inducement Performance Stock Unit Agreement for Cecilia JonesS-8333- 267624September 26, 202299.310.29#Amended and Restated Severance Benefits Plan8-K001-36014October 7, 202210.